Psychiatry

814 questions

Question 641Question →

A 34-year-old man with a 5-year history of severe heroin use disorder presents to an outpatient addiction clinic seeking treatment. He reports that his last heroin use was 2 hours ago. He is highly motivated to stop using illicit opioids and requests to start buprenorphine/naloxone therapy immediately. To appropriately initiate and maintain his treatment while avoiding iatrogenic complications, arrange the following management steps in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first delay the induction, verify objective signs of withdrawal, administer the initial dose, titrate the dose upward, and finally establish long-term maintenance.
Buprenorphine is a partial agonist with very high affinity for the mu-opioid receptor. If administered while a full agonist (like heroin) is still occupying the receptors, buprenorphine competitively displaces the heroin but provides less receptor activation, immediately causing severe 'precipitated withdrawal'. Therefore, the first step is to delay induction until the full agonist has cleared. Second, the clinician must objectively verify the onset of spontaneous withdrawal (e.g., using a standardized scale). Only then is the initial test dose administered. Once induction is successful, the dose is titrated to suppress cravings, followed by long-term maintenance combined with psychosocial support.

Step-by-Step Solution

1
Identify the primary pharmacological risk in initiating buprenorphine for a patient recently exposed to heroin.
The primary risk is precipitated withdrawal due to buprenorphine's high receptor affinity and partial agonist properties.
Buprenorphine displaces heroin from mu-opioid receptors. If administered too soon, the sudden shift to a partial agonist causes an acute, severe withdrawal syndrome.
2
Determine the necessary prerequisite before the first buprenorphine dose can be administered.
The patient must wait for the full agonist to clear from their system.
Waiting (typically 12-24 hours for heroin) ensures the receptors are no longer fully occupied, mitigating the risk of precipitated withdrawal.
3
Determine how to objectively measure readiness for the first dose.
The clinician assesses the patient using a standardized tool to confirm mild-to-moderate withdrawal.
Objective signs (e.g., using the Clinical Opiate Withdrawal Scale) confirm the safe therapeutic window for induction.
4
Sequence the remaining pharmacological steps.
Following confirmation of withdrawal, the initial dose is given, and the dosage is titrated over several days to achieve craving suppression.
Induction requires careful initial dosing followed by a titration phase to find the optimal steady-state dose.
5
Identify the long-term management strategy.
Long-term maintenance integrates the stabilized pharmacotherapy with behavioral counseling.
Medication for opioid use disorder is most effective when paired with comprehensive psychosocial interventions.

Key Concept

Buprenorphine Induction and Prevention of Precipitated Withdrawal
Estimated Time:1m 30s
Question 642Question →

A 15-year-old girl is admitted to the inpatient pediatric unit for severe anorexia nervosa, restricting type. She has a body mass index (BMI) of 13.2 kg/m², a heart rate of 42/min, and blood pressure of 88/55 mm Hg. Physical examination shows lanugo, temporal wasting, and acrocyanosis. Arrange the following interventions in the most appropriate clinical sequence for the management of this patient, from initial inpatient evaluation to definitive post-hospitalization care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: (1) Obtain a baseline electrocardiogram and assess electrolytes, (2) Initiate gradual nutritional rehabilitation, (3) Perform daily monitoring of serum electrolytes, and (4) Engage the patient and parents in outpatient family-based therapy (FBT).
The management of severe anorexia nervosa requires a structured, sequential approach prioritizing medical safety. First, baseline electrolytes and an ECG must be obtained to assess for existing derangements and the immediate risk of arrhythmias. Second, gradual nutritional rehabilitation is initiated to slowly reverse the starvation state. Third, because the reintroduction of carbohydrates stimulates insulin release and drives phosphorus, potassium, and magnesium into cells, daily electrolyte monitoring and aggressive repletion are crucial to prevent refeeding syndrome. Finally, once the patient is medically stabilized, the focus shifts to long-term psychiatric recovery, for which family-based therapy (FBT) is the first-line treatment in adolescents.

Step-by-Step Solution

1
Assess initial clinical and metabolic status.
Baseline ECG and comprehensive metabolic parameters are obtained.
Severely malnourished patients are at immediate risk for fatal arrhythmias and baseline electrolyte derangements, which must be identified before any intervention.
2
Begin medical management of starvation.
Gradual caloric reintroduction is initiated.
Starting with a low caloric intake prevents a rapid insulin surge that causes severe intracellular shifts of electrolytes, thereby mitigating the risk of refeeding syndrome.
3
Monitor and manage acute complications of refeeding.
Electrolytes are checked daily and repleted as needed.
Refeeding syndrome typically manifests within the first few days of nutritional rehabilitation; close monitoring prevents clinical deterioration.
4
Plan definitive long-term psychiatric treatment.
Family-based therapy (FBT) is initiated upon discharge.
Once medically stable, FBT is the evidence-based gold standard for adolescents with anorexia nervosa to achieve long-term weight restoration and behavioral change.

Key Concept

Sequential management of severe anorexia nervosa prioritizes acute medical stabilization (baseline assessment followed by careful refeeding and monitoring) before transitioning to longitudinal psychiatric care.
Question 643Question →

A 24-year-old man with a recent diagnosis of schizophrenia is admitted to the inpatient psychiatric unit due to worsening paranoia and auditory hallucinations. He is started on high-dose oral haloperidol. As part of patient education, the attending physician discusses the potential adverse extrapyramidal symptoms (EPS) associated with this medication. Arrange the following clinical presentations of EPS in chronological order according to their typical peak onset after initiating the antipsychotic, from earliest (hours/days) to latest (months/years).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Acute dystonia (muscle contractions), followed by Akathisia (restlessness), followed by Drug-induced parkinsonism (rigidity/tremor), and finally Tardive dyskinesia (choreoathetoid movements).
The correct sequence follows the classic chronological pattern of extrapyramidal symptom (EPS) onset following typical antipsychotic initiation (often taught as the 'Rule of 4s'). Acute dystonia, characterized by sustained muscle spasms, occurs earliest (within 4 hours to 4 days). Akathisia, a profound subjective restlessness, follows next (within 4 days to 4 weeks). Drug-induced parkinsonism, marked by bradykinesia and rigidity, occurs third (within 4 weeks to 4 months). Tardive dyskinesia, featuring involuntary choreoathetoid movements, is a late complication occurring after prolonged exposure (4 months to years).

Step-by-Step Solution

1
Identify the specific extrapyramidal symptom (EPS) described in each clinical presentation item.
The items describe acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia, respectively.
Recognizing the clinical phenotype is required before the temporal onset rules can be applied.
2
Determine the typical onset timeline for each identified EPS condition.
Acute dystonia occurs in hours to days, akathisia in days to weeks, parkinsonism in weeks to months, and tardive dyskinesia in months to years.
EPS onset follows a well-established chronological pattern driven by the timeline of central dopamine (D2) receptor blockade and subsequent receptor upregulation.
3
Order the presentations sequentially based on the established timelines.
The correct sequence is Dystonia -> Akathisia -> Parkinsonism -> Tardive dyskinesia.
This sequence correctly reflects the earliest expected onset to the latest expected onset.

Key Concept

The temporal progression of typical antipsychotic-induced extrapyramidal symptoms.
Question 644Question →

A 28-year-old man presents to a primary care clinic with a 2-month history of worsening mood, severe fatigue, and lack of motivation. He reports sleeping up to 12 hours a day but still feeling exhausted upon waking. Additionally, he has experienced a significant increase in appetite, resulting in a 6 kg (13.2 lb) weight gain over the past month. He describes a pervasive sensation of extreme heaviness in his arms and legs, making it difficult to get out of bed. His past medical history is notable for a severe depressive episode at age 20. At that time, he was prescribed a medication that he discontinued after 3 weeks because it made him feel "too wired and agitated." He is currently not taking any medications. Vital signs and physical examination are unremarkable. The physician is considering starting an antidepressant. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Inquire about periods of excessive energy, racing thoughts, and decreased need for sleep

Answer

The most appropriate next step is to inquire about periods of excessive energy, racing thoughts, and decreased need for sleep to rule out bipolar disorder.
The correct approach is to inquire about periods of excessive energy, racing thoughts, and decreased need for sleep. This patient presents with a major depressive episode characterized by atypical features (hypersomnia, hyperphagia, weight gain, and leaden paralysis). A crucial red flag in his history is the 'wired and agitated' reaction to a previously prescribed medication (likely an antidepressant). This adverse reaction, combined with early-onset depression and atypical features, is highly suggestive of bipolar disorder. Standard medical guidelines require that all patients presenting with a depressive episode be screened for a history of mania or hypomania before initiating antidepressant therapy to prevent an iatrogenic manic switch.

Step-by-Step Solution

1
Identify the primary symptom cluster.
The patient presents with hypersomnia, hyperphagia, weight gain, and leaden paralysis (heavy limbs) alongside low mood.
These symptoms define major depressive disorder with atypical features.
2
Analyze historical red flags.
The patient had a previous severe depressive episode at age 20 and experienced a 'wired and agitated' reaction to a prescribed medication.
Early onset of depression, atypical features, and activation/agitation on antidepressants are strong indicators of an underlying bipolar spectrum disorder.
3
Determine the necessary clinical action before treatment.
The physician must screen for a lifetime history of manic or hypomanic episodes.
Prescribing antidepressant monotherapy to a patient with bipolar disorder can precipitate a manic switch. It is critical to confirm whether the depressive disorder is unipolar or bipolar before initiating pharmacotherapy.

Key Concept

All patients presenting with a depressive episode must be screened for a lifetime history of mania or hypomania to rule out bipolar disorder prior to initiating antidepressant monotherapy. This is especially critical in patients with atypical features or a history of antidepressant-induced activation.
Estimated Time:1m 0s
Question 645Question →

A 19-year-old male college student is brought to the psychiatric clinic by his parents. Eight weeks ago, he was admitted to the emergency department with severe agitation, paranoia, and auditory hallucinations after using synthetic cathinones at a party. He was hospitalized, and his acute intoxication resolved over 3 days. However, his parents report that since his discharge 7 weeks ago, he has continued to hear voices and firmly believes that his professors have planted listening devices in his dormitory. For the past 7 weeks, he has been living at home under strict parental supervision with no access to drugs or alcohol, and weekly random urine toxicology screens have been consistently negative. Over the last two weeks, he has also developed a markedly blunted affect and speaks only in short, one-word answers. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophreniform disorder

Answer

Schizophreniform disorder
The patient presents with delusions, auditory hallucinations, and negative symptoms (blunted affect, alogia), which fulfill Criterion A for a schizophrenia spectrum disorder. Although the psychotic episode was initially triggered by synthetic cathinone use, the symptoms have persisted for 7 weeks despite documented, continuous abstinence. According to the DSM-5, a substance-induced psychotic disorder should only be diagnosed if the symptoms resolve within approximately 1 month of the cessation of acute intoxication or withdrawal. Because the symptoms have persisted beyond this 1-month threshold in a clear sensorium, the etiology is reclassified as a primary psychotic disorder. The total duration of the illness is 8 weeks (more than 1 month but less than 6 months), which strictly meets the diagnostic criteria for schizophreniform disorder.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms.
The patient exhibits delusions, auditory hallucinations, and negative symptoms (blunted affect, alogia), meeting Criterion A for a schizophrenia spectrum disorder.
Establishing the clinical syndrome is the first step in psychiatric diagnosis.
2
Evaluate the etiology by assessing the timeline relative to substance use.
The symptoms began after synthetic cathinone use but have persisted for 7 weeks despite documented continuous abstinence.
Substance-induced psychotic disorder requires symptoms to resolve within approximately 1 month after the cessation of acute intoxication or withdrawal. Persistence beyond this indicates a primary psychotic disorder.
3
Apply duration criteria to classify the primary psychotic disorder.
The total duration of the illness is 8 weeks. This falls within the 1-month to 6-month timeframe.
A duration of 1 to 6 months defines schizophreniform disorder, distinguishing it from brief psychotic disorder (<1 month) and schizophrenia (≥6 months).

Key Concept

Psychotic symptoms that persist for longer than 1 month after the cessation of substance intoxication or withdrawal represent a primary psychotic disorder, which is then classified based on total illness duration (e.g., schizophreniform disorder for 1-6 months).
Question 646Question →

A 20-year-old man is brought to the emergency department by his roommates due to severe agitation and paranoia. Over the past 4 days, he has barricaded himself in his dorm room, claiming that the university administration has installed hidden cameras to steal his thoughts. He frequently yells at voices that no one else can hear. His roommates report that he has no prior psychiatric history but has been extremely stressed about upcoming final exams. Vital signs show a temperature of 37.9°C (100.2°F), blood pressure of 162/98 mm Hg, and pulse of 118/min. Physical examination reveals pronounced diaphoresis, bilateral mydriasis, and mild fine hand tremors. He is hypervigilant, oriented to person, place, and time, and admits to recently using a 'study aid' given to him by a friend to help him stay awake. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Substance/medication-induced psychotic disorder

Answer

Substance/medication-induced psychotic disorder
The correct answer identifies that the patient's acute psychotic symptoms (paranoia, auditory hallucinations) are a direct physiological consequence of a substance. The patient's presentation of prominent autonomic hyperactivity (tachycardia, hypertension, diaphoresis, mydriasis) alongside the ingestion of an unknown 'study aid' is a classic presentation of psychostimulant (e.g., amphetamine) intoxication. According to DSM-5 criteria, a primary psychotic disorder cannot be diagnosed if the symptoms are attributable to the physiological effects of a substance.

Step-by-Step Solution

1
Identify the primary psychiatric symptoms.
The patient exhibits acute-onset paranoia, persecutory delusions, and auditory hallucinations lasting for 4 days.
Establishing the specific nature and temporal course of the psychotic symptoms is the first step in formulating a psychiatric differential diagnosis.
2
Analyze the patient's vital signs and physical examination findings.
The patient demonstrates significant autonomic hyperactivity, including tachycardia (118/min), hypertension (162/98 mm Hg), diaphoresis, and bilateral mydriasis.
Physical signs are crucial for distinguishing primary psychiatric conditions from secondary organic causes, such as medical illnesses or toxidromes.
3
Correlate the clinical presentation with the patient's history.
The combination of acute psychosis, a classic sympathetic toxidrome, and the recent use of an unknown 'study aid' strongly indicates psychostimulant (e.g., amphetamine) intoxication.
By strict DSM-5 criteria, a primary psychiatric diagnosis cannot be made if the symptoms are the direct physiological consequence of a substance or medication.
4
Exclude primary psychotic disorders based on duration and etiology.
Brief psychotic disorder is excluded because the symptoms are substance-induced. Schizophreniform disorder and schizophrenia are excluded due to both the substance etiology and the excessively short 4-day symptom duration.
Strict application of DSM-5 diagnostic criteria ensures accurate classification and guides appropriate acute management.

Key Concept

Differentiating substance-induced psychotic disorder from primary psychotic disorders based on clinical signs of intoxication and symptom duration.
Estimated Time:1m 0s
Question 647Question →

A 48-year-old male postal worker is brought to the outpatient clinic by his sister due to a one-month history of profound sadness, severe lack of energy, and sleeping up to 14 hours a day. The patient states he feels constantly sluggish, has gained 5 kg (11 lbs) over the last month, and struggles to maintain concentration while sorting mail at work. He has no significant past medical history and takes no medications. Vital signs are within normal limits. Physical examination reveals no abnormalities. On mental status examination, the patient exhibits notable psychomotor retardation, a depressed mood, and a restricted affect. He denies suicidal ideation as well as auditory or visual hallucinations. When specifically asked about his past psychiatric history, his sister notes that three years ago, he experienced a three-week period where he was unusually talkative, slept only 2 to 3 hours a night without feeling tired, and relentlessly painted both his entire house and the neighbor's fence, claiming to possess "limitless energy." This previous episode resolved without medical intervention. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Prescribe lithium carbonate

Answer

Prescribe lithium carbonate.
The patient is currently experiencing a major depressive episode but has a clear history of a manic episode (characterized by decreased need for sleep, increased goal-directed activity, and expansive mood), firmly establishing a diagnosis of bipolar I disorder. In patients with bipolar depression, standard treatment must avoid unopposed antidepressants. First-line agents include mood stabilizers (such as lithium or valproate) or specific second-generation antipsychotics. Lithium carbonate is a highly effective, classical first-line agent for both acute bipolar depression and long-term maintenance therapy.

Step-by-Step Solution

1
Analyze the current clinical presentation.
The patient meets the criteria for a major depressive episode.
The patient exhibits depressed mood, hypersomnia, weight gain, fatigue, and poor concentration lasting for at least two weeks (one month in this case).
2
Evaluate the past psychiatric history provided by the collateral source (sister).
The patient has a history of a manic episode.
Three years ago, the patient had a distinct three-week period characterized by a decreased need for sleep, increased goal-directed activity, pressured speech, and grandiosity, which confirms a diagnosis of bipolar I disorder.
3
Select the appropriate pharmacotherapy for a patient with bipolar I disorder currently in a depressive episode.
A mood stabilizer such as lithium carbonate is the correct treatment.
Using antidepressant monotherapy in patients with bipolar disorder can precipitate a manic switch. First-line treatments for acute bipolar depression include lithium, specific second-generation antipsychotics, or lamotrigine.

Key Concept

Management of acute depression in Bipolar I Disorder and avoidance of antidepressant monotherapy.
Estimated Time:1m 30s
Question 648Question →

A 58-year-old man presents to the clinic for evaluation of progressive fatigue and poor concentration over the past 6 months. He states that he sleeps 8 hours each night but frequently awakens feeling unrefreshed and with a diffuse morning headache. His wife reports that he snores loudly and occasionally appears to stop breathing for short periods, often waking up with a sudden gasp. He consumes 2 to 3 alcoholic beverages nightly. His medical history includes type 2 diabetes mellitus and hypertension. Current medications are metformin and lisinopril. BMI is 34 kg/m234 \text{ kg/m}^2. Blood pressure is 152/94 mmHg152/94 \text{ mmHg}, pulse is 78/min78 \text{/min}, and respirations are 14/min14 \text{/min}. Cardiopulmonary examination reveals clear lungs bilaterally, regular heart rhythm without murmurs, and no jugular venous distention. Laboratory studies show a normal serum thyroid-stimulating hormone concentration. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Perform overnight polysomnography

Answer

The correct answer is to perform overnight polysomnography.
This patient presents with a classic clinical picture of Obstructive Sleep Apnea (OSA), characterized by daytime fatigue, unrefreshing sleep, diffuse morning headaches, loud snoring, and witnessed apneic episodes terminating in gasps. His risk factors include obesity (BMI > 30), male sex, advancing age, and evening alcohol use, which relaxes upper airway musculature. The most appropriate next step in management for a patient with high clinical suspicion for OSA is an overnight polysomnography (sleep study). This test definitively diagnoses OSA by measuring the Apnea-Hypopnea Index (AHI) and guides subsequent treatment, such as continuous positive airway pressure (CPAP) therapy or lifestyle modifications.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
Identify classic symptoms of Obstructive Sleep Apnea (OSA), including obesity, loud snoring, witnessed apneas, morning headaches, and unrefreshing sleep.
Recognizing the constellation of symptoms is essential to form the correct primary differential diagnosis.
2
Differentiate the symptoms from other etiologies.
Rule out heart failure (normal cardiopulmonary exam), hypothyroidism (normal TSH), and primary depression (airway symptoms are dominant).
Fatigue and sleep disturbances have a broad differential that must be narrowed using physical exam and basic laboratory findings.
3
Determine the initial diagnostic standard for the suspected condition.
Select polysomnography to formally diagnose and quantify the severity of the suspected OSA.
A sleep study is required to calculate the Apnea-Hypopnea Index (AHI) before initiating treatments like CPAP.

Key Concept

Diagnosis of Obstructive Sleep Apnea requires polysomnography to confirm the presence and severity of apneic episodes.
Question 649Question →

A 62-year-old retired architect with a long-standing history of bipolar I disorder is evaluated in the emergency department for worsening confusion, sluggishness, and an unsteady gait over the past three days. He has been psychiatrically stable on a fixed dose of lithium carbonate for eight years without any recent dosage adjustments. His husband reports that the patient recently started taking an over-the-counter analgesic multiple times a day for a severe flare-up of knee osteoarthritis. Vital signs are within normal limits. Physical examination reveals a coarse, irregular tremor in both upper extremities and pronounced dysarthria. The patient is unable to perform tandem walking without losing his balance. Which of the following mechanisms best explains how the newly initiated analgesic precipitated this patient's current symptoms?

Show answer & explanation

Answer: Decreased renal clearance secondary to afferent arteriole vasoconstriction

Answer

The over-the-counter medication (an NSAID) precipitated toxicity via decreased renal clearance secondary to afferent arteriole vasoconstriction.
The correct answer accurately describes the mechanism of NSAID-induced lithium toxicity. This patient is presenting with classic symptoms of lithium toxicity (coarse tremor, ataxia, dysarthria, and altered mental status). His recent initiation of an over-the-counter analgesic for osteoarthritis points strongly to a nonsteroidal anti-inflammatory drug (NSAID). NSAIDs inhibit cyclooxygenase (COX), leading to decreased synthesis of prostaglandins. In the kidney, prostaglandins are responsible for maintaining vasodilation of the afferent arteriole. Loss of this dilatory effect results in afferent arteriole vasoconstriction, a decreased glomerular filtration rate (GFR), and subsequently decreased renal clearance of lithium. Because lithium has a very narrow therapeutic index, this reduction in clearance rapidly leads to toxic serum levels.

Step-by-Step Solution

1
Diagnose the patient's acute clinical presentation based on symptoms and medication history.
The patient is experiencing acute lithium toxicity, characterized by confusion, coarse tremors, ataxia, and dysarthria in the setting of chronic lithium use.
Lithium has a narrow therapeutic index, and its neurological toxicities classically include coarse tremor, cerebellar dysfunction (ataxia, dysarthria), and altered mental status.
2
Identify the likely over-the-counter medication taken for the patient's osteoarthritis.
The patient is most likely taking a nonsteroidal anti-inflammatory drug (NSAID) such as ibuprofen or naproxen.
NSAIDs are standard, widely available over-the-counter first-line analgesics for osteoarthritis flare-ups.
3
Determine the pharmacological mechanism by which NSAIDs interact with lithium.
NSAIDs inhibit cyclooxygenase (COX), reducing renal prostaglandins. This causes afferent arteriole vasoconstriction, dropping the glomerular filtration rate (GFR) and decreasing the renal clearance of lithium.
Lithium is filtered exclusively by the kidneys. Any drug that reduces GFR (NSAIDs) or increases proximal tubular reabsorption (thiazides, ACE inhibitors) will lead to toxic accumulation of lithium.

Key Concept

Lithium relies entirely on renal clearance. Medications that decrease glomerular filtration rate, such as NSAIDs (via afferent arteriole vasoconstriction), can precipitate dangerous lithium toxicity.
Question 650Question →

Match each patient's clinical presentation to the most appropriate psychiatric diagnosis.

Click a left item, then click its matching right item

Items

A 22-year-old man is evaluated for severe agitation and disorganized speech that began 2 weeks ago. He is convinced his professors have placed hidden cameras in his room. He has no prior psychiatric history.
A 29-year-old woman is evaluated for continuous auditory hallucinations and profound avolition. Her symptoms began 4 months ago. She has no history of major depressive or manic episodes.
A 24-year-old man presents with a 1-year history of worsening social withdrawal, flattened affect, and persecutory delusions. His academic performance has significantly declined over this period.
A 35-year-old woman firmly believes a famous actor is secretly in love with her. She has maintained this belief for 6 months. She continues to work successfully as an attorney and has no hallucinations or disorganized behavior.
A 27-year-old man with a 3-year history of recurrent major depressive episodes has experienced persistent auditory hallucinations for the past year. Notably, he had a 4-week period where his mood was completely normal, but the hallucinations continued.

Matches

Show answer & explanation

Answer

1 matches with Brief Psychotic Disorder; 2 matches with Schizophreniform Disorder; 3 matches with Schizophrenia; 4 matches with Delusional Disorder; 5 matches with Schizoaffective Disorder.
Each diagnosis is firmly established by careful evaluation of symptom duration, presence of concurrent mood episodes, and overall functional impairment as outlined in the DSM-5 criteria.

Step-by-Step Solution

1
Analyze the duration of psychotic symptoms for each patient.
Patient 1: 2 weeks; Patient 2: 4 months; Patient 3: 1 year.
Total duration of illness is the primary differentiator among Brief Psychotic Disorder (<1 month), Schizophreniform Disorder (1-6 months), and Schizophrenia (>6 months).
2
Evaluate the presence of mood episodes and their temporal relationship to psychotic symptoms.
Patient 5 has recurrent major depressive episodes but also a 4-week period of psychosis without mood symptoms.
Documenting psychotic symptoms for more than 2 weeks in the absence of mood symptoms distinguishes Schizoaffective Disorder from a Major Depressive Disorder with psychotic features.
3
Assess the nature of the delusion and the patient's level of functioning.
Patient 4 has an isolated erotomanic delusion for 6 months without other psychotic symptoms and with preserved occupational functioning.
Isolated delusions with a lack of significant overall functional impairment define Delusional Disorder.

Key Concept

The differential diagnosis of primary psychotic disorders relies heavily on the exact timeline of symptoms, overall functional decline, and the relationship between psychotic and mood episodes.
Estimated Time:1m 30s
Question 651Question →

Match the following neurocognitive or related psychiatric conditions with their most appropriate initial pharmacological management strategy or critical therapeutic constraint.

Click a left item, then click its matching right item

Items

Dementia with Lewy bodies (DLB) presenting with distressing visual hallucinations
Behavioral variant frontotemporal dementia (bvFTD) presenting with severe impulsivity
Mild-to-moderate Alzheimer disease newly diagnosed in the outpatient setting
Major depressive disorder presenting with dementia-like cognitive impairment (pseudodementia)

Matches

Show answer & explanation

Answer

Dementia with Lewy bodies matches with neuroleptic sensitivity; Behavioral variant frontotemporal dementia matches with SSRI use for behaviors and avoiding cholinesterase inhibitors; Alzheimer disease matches with initiating acetylcholinesterase inhibitors; Pseudodementia matches with antidepressant therapy reversing cognitive deficits.
Each condition pairs with a unique and essential pharmacological principle: DLB requires avoiding typical antipsychotics, bvFTD relies on SSRIs while avoiding AChE inhibitors, Alzheimer disease is primarily treated with AChE inhibitors, and pseudodementia cognitive deficits are reversible with antidepressants.

Step-by-Step Solution

1
Analyze the management of Dementia with Lewy bodies.
Identify the critical contraindication of typical antipsychotics due to extreme neuroleptic sensitivity.
Exposure to typical antipsychotics in DLB can be fatal or cause severe, irreversible parkinsonism.
2
Evaluate treatments for behavioral variant frontotemporal dementia.
Select symptom-targeted management (SSRIs) and recognize that cognitive enhancers (donepezil) are ineffective and potentially harmful.
bvFTD involves frontal lobe atrophy affecting behavior; cholinergic deficits are not the primary pathophysiology, so AChE inhibitors can increase agitation.
3
Determine standard treatment for Alzheimer disease.
Select acetylcholinesterase inhibitors as the foundational initial therapy.
Alzheimer disease is characterized by a central cholinergic deficit, which is temporarily ameliorated by AChE inhibitors.
4
Identify the treatment goal for pseudodementia.
Select antidepressant therapy with the expectation of cognitive reversal.
The cognitive impairment in pseudodementia is secondary to major depressive disorder; treating the mood disorder resolves the cognitive deficits.

Key Concept

Pharmacological management and critical contraindications in major neurocognitive disorders
Question 652Question →

Match each clinical scenario involving a patient with an anxiety, obsessive-compulsive, or trauma-related disorder to the most appropriate next step in pharmacological management.

Click a left item, then click its matching right item

Items

A 35-year-old with PTSD has achieved remission of daytime hyperarousal on maximal-dose sertraline but continues to experience frequent, highly distressing trauma-related nightmares.
A 29-year-old with Generalized Anxiety Disorder requests a daily maintenance medication but adamantly refuses SSRIs and SNRIs due to a history of severe medication-induced sexual dysfunction.
A 22-year-old with severe OCD has achieved only a minimal reduction in symptoms after 14 weeks of high-dose fluoxetine combined with rigorous exposure and response prevention therapy.
A 41-year-old with Panic Disorder and a recent history of severe alcohol use disorder requires short-acting symptomatic relief for acute panic attacks while awaiting the full onset of a newly initiated SSRI.

Matches

Show answer & explanation

Answer

The scenarios match with their management steps as follows: PTSD with nightmares matches alpha-1 antagonist addition; GAD with SSRI-induced sexual dysfunction matches buspirone; treatment-resistant OCD matches atypical antipsychotic augmentation; and Panic Disorder in a patient with SUD matches as-needed antihistamine.
Each clinical scenario requires a specific nuance in psychopharmacology. PTSD nightmares respond well to alpha-1 blockade (prazosin). GAD requiring non-sexual-dysfunction-inducing therapy is best managed with buspirone. SSRI-resistant OCD benefits from atypical antipsychotic augmentation. Acute panic in patients with substance use disorders requires non-addictive PRN agents like hydroxyzine.

Step-by-Step Solution

1
Analyze the patient with PTSD experiencing residual nightmares.
Identify that while daytime symptoms are managed with sertraline, nightmares persist.
Prazosin (an alpha-1 blocker) specifically targets sympathetic hyperarousal during sleep, reducing PTSD nightmares without disrupting the primary SSRI regimen.
2
Evaluate the patient with GAD requiring maintenance therapy without sexual side effects.
Rule out SSRIs and SNRIs.
Buspirone is a 5-HT1A receptor partial agonist used for GAD that lacks the sexual side effects typical of serotonergic antidepressants.
3
Assess the patient with OCD who is refractory to high-dose SSRI and ERP.
Determine the need for pharmacological augmentation rather than simply switching SSRIs.
Atypical antipsychotics (like aripiprazole) are the best-evidenced augmentation strategy for SSRI-refractory OCD in current clinical guidelines.
4
Consider the patient with Panic Disorder needing acute symptom relief who has a history of alcohol use disorder.
Avoid benzodiazepines due to the high risk of relapse, misuse, and dangerous pharmacological interactions.
Hydroxyzine offers a safe, non-addictive PRN alternative for acute anxiety symptoms in patients with substance use histories.

Key Concept

Pharmacological management of anxiety, OCD, and trauma-related disorders requires tailoring interventions based on specific residual symptoms, medication side effect profiles, treatment resistance, and comorbid substance use disorders.
Question 653Question →

A 45-year-old woman is evaluated on the medical ward by the psychiatric consultation-liaison service due to acute-onset agitation and confusion. The patient has a history of major depressive disorder, which has been well controlled on sertraline 150 mg daily for the past two years, and poorly controlled type 2 diabetes mellitus. She was admitted three days ago for a severe diabetic foot infection. Deep tissue cultures grew Vancomycin-resistant Enterococcus faecium (VRE). Yesterday, her intravenous antibiotics were discontinued, and she was transitioned to a targeted oral antibiotic therapy to facilitate hospital discharge. This morning, she became rapidly disoriented and restless. Temperature is 38.6°C (101.5°F), blood pressure is 165/95 mm Hg, pulse is 128/min, and respirations are 20/min. Physical examination reveals a diaphoretic, flushed woman who is unable to answer questions coherently. Her pupils are dilated (6 mm bilaterally). Neurologic examination is notable for 4+ deep tendon reflexes in the lower extremities, spontaneous myoclonus, and sustained bilateral ankle clonus. Which of the following pharmacologic actions of the newly initiated antibiotic is most directly responsible for this patient's current clinical state?

Show answer & explanation

Answer: Inhibition of monoamine oxidase

Answer

Inhibition of monoamine oxidase
This patient's presentation of altered mental status, autonomic instability (fever, tachycardia, hypertension, diaphoresis), and profound neuromuscular hyperactivity (myoclonus, hyperreflexia, sustained clonus) represents the classic triad of serotonin syndrome. The patient was already taking sertraline, a selective serotonin reuptake inhibitor (SSRI). The abrupt onset of symptoms followed the initiation of a targeted oral antibiotic for Vancomycin-resistant Enterococcus (VRE). Linezolid is an oxazolidinone antibiotic frequently used for VRE and methicillin-resistant Staphylococcus aureus (MRSA) infections. A critical pharmacological characteristic of linezolid is its structural similarity to monoamine oxidase inhibitors (MAOIs), which gives it weak, reversible, nonselective MAOI activity. When administered with an SSRI, linezolid inhibits the enzymatic degradation of serotonin while the SSRI inhibits its reuptake. This leads to a massive accumulation of synaptic serotonin and precipitates serotonin syndrome. Concurrent use of linezolid and serotonergic antidepressants is contraindicated.

Step-by-Step Solution

1
Identify the patient's acute toxidrome from the clinical presentation.
The patient has altered mental status, autonomic instability (fever, tachycardia, hypertension, diaphoresis), and neuromuscular hyperactivity (hyperreflexia, myoclonus, clonus).
This triad is the classic clinical presentation of serotonin syndrome.
2
Determine the inciting pharmacological trigger.
The patient was stable on sertraline (an SSRI) and developed the syndrome shortly after starting a new oral antibiotic for VRE.
Linezolid is a primary oral treatment option for VRE infections and is known to cause severe drug interactions.
3
Identify the mechanism by which the antibiotic caused this syndrome.
Linezolid possesses weak, reversible nonselective monoamine oxidase inhibitor (MAOI) activity.
Combining an MAOI (linezolid) with an SSRI (sertraline) prevents the breakdown and reuptake of serotonin, leading to a massive accumulation of serotonin in the central nervous system, precipitating serotonin syndrome.

Key Concept

Linezolid has off-target monoamine oxidase inhibitor (MAOI) properties and can precipitate life-threatening serotonin syndrome when co-administered with serotonergic agents like SSRIs.
Estimated Time:2m 0s
Question 654Question →

A 32-year-old man is brought to the emergency department by emergency medical services after he was found violently striking parked cars and yelling that "aliens are trying to abduct me." The patient's medical records indicate a history of bipolar I disorder and opioid use disorder. He is currently prescribed lithium and phenelzine. Vital signs are temperature 38.3°C (101.0°F), pulse 132/min, respirations 22/min, and blood pressure 165/100 mm Hg. Physical examination reveals prominent horizontal and vertical nystagmus, diaphoresis, and a lack of pain response when minor lacerations on his hands are examined. The patient is physically restrained for staff safety but continues to struggle aggressively. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous lorazepam

Answer

The most appropriate next step is to administer intravenous lorazepam.
The patient's presentation of severe agitation, bizarre and violent behavior, autonomic instability, decreased pain perception, and characteristic horizontal and vertical nystagmus strongly points to phencyclidine (PCP) intoxication. In the acute setting, PCP intoxication is a medical emergency due to the high risk of trauma, seizures, and severe rhabdomyolysis resulting from prolonged muscle contractions. The first-line management for severe agitation and aggression associated with PCP is the administration of parenteral benzodiazepines, such as lorazepam. Benzodiazepines effectively provide chemical restraint, raise the seizure threshold, and promote muscle relaxation without interacting dangerously with his current medications.

Step-by-Step Solution

1
Identify the primary toxidrome based on the clinical presentation.
The patient exhibits severe agitation, psychosis, autonomic hyperactivity, analgesia, and prominent horizontal/vertical nystagmus.
These findings are the classic triad of acute phencyclidine (PCP) intoxication.
2
Determine the priority in acute management.
The immediate goal is to safely control the patient's severe agitation and aggressive behavior.
Agitation in PCP intoxication can lead to hyperthermia, seizures, and severe rhabdomyolysis, posing a direct threat to the patient's life and staff safety.
3
Select the appropriate pharmacological intervention while avoiding contraindicated drug interactions.
Parenteral benzodiazepines (e.g., lorazepam) are chosen as the first-line treatment.
Benzodiazepines rapidly sedate the patient, raise the seizure threshold, and relax muscles. Other agents, such as meperidine, are avoided due to the patient's concurrent phenelzine use.

Key Concept

The primary acute management for phencyclidine (PCP) intoxication involves ensuring safety and administering benzodiazepines to control severe agitation and prevent systemic complications.
Question 655Question →

A 25-year-old man is brought to the emergency department by his family due to severely erratic behavior. He is speaking rapidly, pacing the examination room, and claims he has not slept in a week because he is "solving the global energy crisis." He also reports hearing voices praising his supreme intellect. His family notes that he has a 4-year history of recurrent, severe depressive and manic episodes that have required multiple hospitalizations. Notably, 6 months ago, his mood was entirely stable and normal for a 4-week period, but he persistently heard voices and believed his neighbors were spying on him during that entire time. His vital signs and physical examination are unremarkable, and a urine toxicology screen is negative. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizoaffective disorder

Answer

Schizoaffective disorder
The correct answer is schizoaffective disorder. The diagnosis of schizoaffective disorder requires an uninterrupted period of illness during which there is a major mood episode (manic or depressive) concurrent with the active-phase symptoms of schizophrenia. Crucially, there must also be a history of delusions or hallucinations lasting for at least 2 weeks in the complete absence of a major mood episode. Finally, symptoms meeting criteria for a major mood episode must be present for the majority of the total duration of the active and residual portions of the illness. This patient presents with a manic episode and psychotic symptoms, has a 4-year history predominantly featuring mood episodes, and clearly experienced a 4-week period of psychosis while completely euthymic, perfectly fulfilling all criteria for schizoaffective disorder.

Step-by-Step Solution

1
Identify the patient's current clinical presentation.
The patient is experiencing an acute manic episode (decreased need for sleep, rapid speech, grandiosity) with concurrent psychotic symptoms (auditory hallucinations).
Establishing the current syndrome is the first step in diagnosing psychiatric conditions.
2
Analyze the longitudinal psychiatric history.
The patient has a 4-year history dominated by major mood episodes, but also had a distinct 4-week period of active psychosis (hallucinations and paranoia) while his mood was completely normal (euthymic).
Psychiatric diagnoses depend heavily on the temporal relationship between different symptom clusters over the lifetime of the illness.
3
Differentiate between primary psychotic disorders and mood disorders with psychotic features.
The presence of psychotic symptoms for at least 2 weeks in the absence of a major mood episode distinguishes schizoaffective disorder from bipolar disorder with psychotic features.
This 2-week rule is the core diagnostic criterion separating schizoaffective disorder from mood disorders with psychotic features.

Key Concept

Schizoaffective disorder is differentiated from mood disorders with psychotic features by the presence of delusions or hallucinations for at least 2 weeks in the absence of a major mood episode during the lifetime duration of the illness.
Estimated Time:1m 30s
Question 656Question →

A 76-year-old man is evaluated in the clinic for progressive memory decline. Over the past 9 months, he has been increasingly forgetful, frequently misplacing household items, and recently became lost while driving home from his local grocery store. His son mentions that the patient's wife passed away 12 months ago; initially, the family attributed his forgetfulness to grief. The patient has a medical history of hypertension and bipolar I disorder, for which he has taken valproate for the past 25 years without any recent mood episodes. During the interview, the patient is cheerful, makes good eye contact, and attempts to joke away his memory lapses. When administered a cognitive assessment, he puts forth significant effort but scores 19/30, losing points on orientation, delayed recall, and intersecting pentagons. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate donepezil therapy

Answer

Initiate donepezil therapy
The correct answer is initiating donepezil therapy. This patient presents with a classic progression of Alzheimer disease, characterized by an insidious onset of memory impairment (getting lost in familiar territory) and progressive cognitive decline over 9 months. A critical step in evaluating elderly patients with cognitive decline following a major life stressor (such as the loss of a spouse) is differentiating genuine major neurocognitive disorder from pseudodementia (major depressive disorder). Patients with genuine dementia often attempt to conceal their deficits (e.g., joking away memory lapses) and put forth significant effort on cognitive testing despite objectively failing. In contrast, patients with pseudodementia typically highlight their deficits, exert poor effort, and frequently answer questions with 'I don't know'. Because this patient has genuine dementia, initiating a cholinesterase inhibitor like donepezil is the most appropriate next step in management to help stabilize cognitive functioning.

Step-by-Step Solution

1
Evaluate the clinical presentation to differentiate between genuine major neurocognitive disorder (dementia) and major depressive disorder (pseudodementia).
The patient's insidious 9-month decline, getting lost in familiar places, attempts to conceal deficits through joking, and poor cognitive performance despite high effort strongly indicate genuine dementia.
Bereavement can cause depressive symptoms (pseudodementia) that mimic dementia, but pseudodementia typically presents with poor effort (frequent 'I don't know' answers) and highlighting of cognitive deficits.
2
Determine the appropriate initial management for the confirmed diagnosis.
The patient requires symptomatic treatment for Alzheimer disease.
Cholinesterase inhibitors such as donepezil are first-line pharmacological treatments to temporarily improve cognition and function in major neurocognitive disorders.

Key Concept

Differentiating genuine major neurocognitive disorder from pseudodementia based on clinical presentation and cognitive testing effort.
Question 657Question →

An otherwise healthy 22-year-old college student seeks medical advice because of irrepressible daytime sleepiness that has been present for the last six months. She consistently falls asleep during her morning lectures and on the bus commute, despite maintaining a regular schedule of eight hours of sleep per night. She notes that her nighttime sleep is frequently fragmented. When asked about other symptoms, she describes several alarming episodes where her knees suddenly buckled and she experienced transient facial weakness specifically when laughing at a friend's joke, forcing her to sit down immediately. Additionally, she reports occasionally seeing a frightening, shadowy figure in her room just as she is drifting off to sleep. Her medical history is unremarkable, and she takes no medications or illicit substances. Vital signs and physical examination are within normal limits. Which of the following is most likely to be found during further evaluation of this patient?

Show answer & explanation

Answer: Decreased cerebrospinal fluid hypocretin-1 concentration

Answer

The patient is most likely to have decreased levels of hypocretin-1 (orexin-A) in the cerebrospinal fluid.
The patient's clinical presentation of excessive daytime sleepiness, cataplexy (sudden, transient muscle weakness triggered by strong emotions like laughter), and hypnagogic hallucinations (visual hallucinations occurring at sleep onset) is highly characteristic of narcolepsy type 1. This primary sleep-wake disorder is fundamentally caused by the selective loss of orexin (hypocretin)-producing neurons situated in the lateral hypothalamus. Consequently, a diagnostic lumbar puncture in patients with narcolepsy type 1 classically reveals abnormally low levels of hypocretin-1 in the cerebrospinal fluid.

Step-by-Step Solution

1
Analyze the core clinical symptoms.
The patient presents with excessive daytime sleepiness for 6 months, cataplexy (muscle weakness specifically with laughter), and hypnagogic hallucinations (seeing figures when falling asleep).
Identifying the cardinal symptoms and their exact triggers is the first step in diagnosing a primary sleep-wake disorder.
2
Synthesize the findings to formulate a diagnosis.
The combination of irrepressible daytime sleepiness, cataplexy, and hypnagogic hallucinations is pathognomonic for narcolepsy type 1.
Grouping the symptoms helps differentiate narcolepsy from other causes of hypersomnia, such as insufficient sleep syndrome or secondary fatigue.
3
Identify the underlying pathophysiology and expected diagnostic findings.
Narcolepsy type 1 is caused by the autoimmune destruction of hypocretin (orexin) neurons in the lateral hypothalamus, leading to definitively decreased hypocretin-1 levels in the cerebrospinal fluid.
The question asks for the most likely finding during further evaluation, requiring knowledge of the specific neurochemical marker for this disease.

Key Concept

Narcolepsy Type 1 pathophysiology and diagnosis
Question 658Question →

A 28-year-old woman is accompanied to an initial psychiatric evaluation by her sister. The patient has been experiencing persistent auditory hallucinations of two voices conversing about her behavior, along with the fixed belief that neighbors are using radar to monitor her thoughts. According to the sister, these symptoms began insidiously 9 months ago and have been continuously present since. The sister also notes that 4 months ago, the patient developed a markedly depressed mood, significant fatigue, poor appetite, and passive suicidal ideation. This distinct period of low mood lasted for precisely 4 weeks before completely resolving. However, the patient's hallucinations and paranoid beliefs remained completely unchanged before, during, and after this 4-week period of depression. She currently exhibits a blunted affect but denies any sadness or anhedonia. The patient takes no medications, and her physical examination and basic laboratory studies are unremarkable. Urine toxicology is negative. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophrenia

Answer

Schizophrenia
The correct answer is Schizophrenia. The patient demonstrates core psychotic symptoms (delusions, auditory hallucinations) and negative symptoms (blunted affect) that have persisted for a total duration of >6 months (9 months in this vignette), satisfying the diagnostic timeline for schizophrenia. While she experienced a concurrent major depressive episode, it is crucial to apply the proportional timeline criteria: in schizophrenia, mood episodes may occur as long as they are present for only a minority of the total duration of the active and residual periods of the illness. Her mood symptoms lasted 4 weeks out of a 36-week (9-month) illness. Because the mood symptoms were not present for the majority of the illness, the diagnosis is schizophrenia, not schizoaffective disorder.

Step-by-Step Solution

1
Analyze the core psychotic symptoms and their total duration.
The patient exhibits delusions, auditory hallucinations, and negative symptoms (blunted affect) that have been continuously present for 9 months.
Establishing the core symptom cluster and total timeline is the first step in differentiating primary psychotic disorders.
2
Identify the presence, duration, and relationship of any mood episodes to the psychotic symptoms.
A discrete 4-week major depressive episode occurred during the 9-month illness. Psychotic symptoms were present both during and outside of this mood episode.
The relationship between mood and psychotic symptoms differentiates schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.
3
Apply the proportional duration criteria for mood episodes within a psychotic illness.
The 4-week mood episode represents a very small minority (approximately 11%) of the total 9-month duration of the psychotic illness.
DSM-5 requires mood symptoms to be present for the 'majority' of the total illness duration for a diagnosis of schizoaffective disorder. Because it is a minority, the diagnosis defaults to schizophrenia.

Key Concept

Differentiating schizophrenia from schizoaffective disorder requires calculating the proportion of time the patient has experienced mood symptoms relative to the total duration of the psychotic illness.
Question 659Question →

An 8-year-old boy is brought to the clinic by his parents due to uncontrollable movements. Over the past 14 months, he has been frequently blinking his eyes forcefully, shrugging his shoulders, and occasionally making loud grunting and throat-clearing noises. These behaviors worsen when he is anxious about school assignments. His parents report that he met all early childhood developmental milestones appropriately. Neurological examination is otherwise unremarkable. Which of the following diagnostic criteria MUST be met to formally diagnose this patient's most likely condition? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Presence of both multiple motor tics and one or more vocal tics at some time during the illness.; The tics have persisted for more than 1 year since the onset of the first tic.; Onset of the tics must occur prior to 18 years of age.

Answer

The condition is Tourette syndrome, which requires the presence of multiple motor tics and at least one vocal tic, persistence of tics for more than 1 year, and symptom onset prior to 18 years of age.
The diagnosis of Tourette syndrome formally requires the presence of multiple motor tics and at least one vocal tic (though they do not have to occur concurrently). Furthermore, these tics must persist for more than 1 year from the onset of the first tic, although they are allowed to wax and wane in severity. Finally, because it is classified as a neurodevelopmental disorder, the onset of symptoms must be documented prior to 18 years of age.

Step-by-Step Solution

1
Analyze the clinical vignette to identify the core symptoms and timeline.
The patient is an 8-year-old presenting with multiple motor tics (eye blinking, shoulder shrugging) and vocal tics (grunting, throat-clearing) that have been present for 14 months.
Establishing the specific types of tics and their duration is critical for differentiating tic disorders.
2
Determine the most likely diagnosis.
The combination of multiple motor tics, vocal tics, and a duration longer than one year indicates Tourette syndrome.
This specific clinical profile perfectly matches the pathognomonic presentation of Tourette syndrome.
3
Evaluate each answer choice against formal DSM-5 criteria for Tourette syndrome.
Multiple motor and vocal tics, persistence for >1 year, and onset before age 18 are required. Milestone delays and continuous 6-month symptoms without tic-free periods are not criteria.
To identify the exact multidomain diagnostic criteria required while eliminating plausible distractor requirements.

Key Concept

DSM-5 diagnostic criteria for Tourette syndrome
Question 660Question →

A 68-year-old man is brought to the clinic by his husband. For the past 8 months, the patient has experienced episodes of shouting, thrashing, and kicking during sleep, typically occurring in the early morning hours. During a recent episode, he accidentally struck his husband in the face. When awakened from these events, the patient reports vivid, action-packed dreams in which he is defending himself from intruders. He has no history of head trauma, seizures, or psychiatric illness. Current medications include a daily multivitamin. Vital signs are within normal limits, and the physical examination, including a detailed neurologic assessment, reveals no abnormalities.

Arrange the following steps in the most appropriate chronological sequence for the diagnostic evaluation and longitudinal management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Video-polysomnography, 2) Environmental safety precautions, 3) Pharmacotherapy, 4) Longitudinal neurodegenerative monitoring.
The evaluation of suspected REM sleep behavior disorder (RBD) must begin with an overnight video-polysomnography to confirm the diagnosis by demonstrating REM sleep without atonia (RSWA) and ruling out mimics. Following a confirmed diagnosis, immediate environmental safety measures (e.g., removing nightstands, placing the mattress on the floor) form the cornerstone of initial non-pharmacologic management to prevent injury. If these safety measures are insufficient or behaviors are intrinsically highly dangerous, pharmacotherapy with melatonin or clonazepam is added as the next step. Finally, because idiopathic RBD is a recognized prodrome for alpha-synucleinopathies, establishing continuous long-term neurological monitoring is essential.

Step-by-Step Solution

1
Identify the likely diagnosis based on the clinical presentation.
The patient's vivid dream enactment in the early morning (REM sleep predominant) strongly suggests REM sleep behavior disorder (RBD).
Establishing the preliminary clinical diagnosis dictates the required diagnostic testing.
2
Determine the necessary objective diagnostic test.
Overnight video-polysomnography is required first.
RBD cannot be diagnosed on clinical history alone; it requires objective demonstration of loss of normal REM sleep atonia and the exclusion of other sleep disorders.
3
Sequence the acute management interventions.
Non-pharmacologic safety measures must be implemented before or alongside medications.
Environmental safety is universally recommended and carries no risk, whereas medications like clonazepam have potential adverse effects in older adults.
4
Identify long-term prognostic needs.
Longitudinal neurological monitoring is established.
A significant majority of patients with idiopathic RBD will eventually develop an alpha-synucleinopathy, requiring long-term surveillance.

Key Concept

REM Sleep Behavior Disorder (RBD) diagnostic and management algorithm
Estimated Time:1m 30s
PreviousPage 33 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 33 | Examkin